Paediatric Consumer Health in Uruguay

2020 IMPACT

In 2020 COVID-19 fuels the growth of previously lacklustre paediatric cough/cold remedies, as well as paediatric vitamins and dietary supplements

In 2020, paediatric consumer health is expected to post a stronger current value growth rate than was seen in 2019. In fact, all subcategories, except for paediatric laxatives and digestive remedies, are expected to post stronger growth in 2020 in comparison to the previous year.

Paediatric analgesics continue to grow, driven by the strong performance of paediatric acetaminophen which was initially recommend by the government for COVID-19

In 2020, paediatric analgesics continued to account for the majority of paediatric consumer health current value sales. Paediatric ibuprofen still represents the majority of current value sales of analgesics, distantly followed by paediatric acetaminophen and then paediatric aspirin.

Bayer continues to lead paediatric vitamins and dietary supplements in 2020, experiencing an upturn from previously declining current value sales

Bayer continued to hold the leading value share in paediatric vitamins and dietary supplements in 2020, benefitting from increased consumption as a result of COVID-19. Its value share declined throughout the review period, and its value growth rate declined from 2013-2018.

RECOVERY AND OPPORTUNITIES

Over the forecast period slower but still solid growth is expected, with paediatric vitamins and dietary supplements set to lead the way

Following the strong performance in 2020, paediatric consumer health is set to slightly slow in current value growth in 2021, and then sustain a stable rate of growth throughout the rest of the forecast period. The forecast current value CAGR is set to be slightly lower than that seen in the review period.

Demand for value-priced generic brands is set to increase over the forecast period

Over the forecast period, consumers are expected to increasingly turn to generic brands as they offer the same effectiveness of branded products, albeit usually at lower prices. Towards the end of the review period, demand for value-priced generic brands was strongly increasing in paediatric analgesics.

Healthier eating habits pose a hurdle to growth over the forecast period

The Uruguayan Public Health Ministry has been very successful at highlighting the fact that essential vitamins can be easily found in readily available and often consumed foods, which might hamper growth of paediatric consumer health over the forecast period. The government has been heavily promoting awareness of what specific foods best provide healthy nutrition, and has not advertised the benefits of supplementing a healthy diet with vitamins.